|
CellCentric and Cancer Research Technology Collaborate on Epigenetic Discoveries.
14th November 2007
[Read article]
CellCentric receives funding from Takeda Research Investment, Inc.
2nd October 2007
[Read article]
CellCentric signs IP agreement with Massachusetts
General Hospital
15th June 2007
[Read article]
Scientific Founder Wins Prestigious Rosenstiel
Award
15th May 2007
[Read article]
CellCentric expands its epigenetic discovery
network
New IP agreement with The University of Texas
M. D. Anderson Cancer Center
29th January 2007
[Read article]
CellCentric raises £1.2m of venture capital
18 July 2006
[Read article]
Drug discovery and commercial experience boost
CellCentric team
28 June 2006
[Read article]
CellCentric receives £1.15m DTI award
4 May 2006
[Read article]
CellCentric announces the appointment of Dr Tim
Fell as Chief Operating Officer (COO)
5 April 2006
[Read article]
CellCentric collaborates with University College
London's Wolfson Institute to accelerate its cancer
drug discovery
1 November 2005
[Read article]
CellCentric and Cancer Research Technology initiate
co-development partnership
26 September 2005
[Read article]
CellCentric receives new funding from NESTA to further
its work in epigenetics and cancer
5 September 2005
[Read article]
CellCentric receives new funding and links up with
the Babraham Institute
7 April 2005
[Read article]
|
